ADMA Biologics ADMA Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| ADMA Bio Manufacturing | $493.17M+9.7% | $493.14M+18.6% | $481.79M+27.5% | $465.32M+42.4% | $449.55M+60.3% | |
| Plasma Collection Centers | $16.7M+69.8% | $17.03M+62.1% | $6.77M+40.6% | $8.86M+160% | $9.83M+256% | |
| Nonoperating Income Expense by Business | ||||||
| ADMA Bio Manufacturing | -$323K-55.3% | -$200K-14.9% | -$268K— | -$303K— | -$208K— | |
| Plasma Collection Centers | $58K+1,550% | -$10K-100% | -$1K— | -$1K— | -$4K— | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest by Business | ||||||
| ADMA Bio Manufacturing | 25,217,200,000%+6,080,700,000pp | 23,507,900,000%+6,025,300,000pp | 19,215,500,000%+4,674,800,000pp | 18,987,400,000%+7,877,000,000pp | 19,136,500,000%+12,088,500,000pp | |
| Plasma Collection Centers | 243,000,000%+729,900,000pp | -536,300,000%-32,200,000pp | -528,400,000%-100,700,000pp | -478,100,000%-78,200,000pp | -486,900,000%-71,100,000pp | |
| Cost Of Revenue by Business | ||||||
| ADMA Bio Manufacturing | $179.75M-13.4% | $199.86M+2.2% | $214.21M+12.7% | $213.96M+23.2% | $207.67M+23.5% | |
| Plasma Collection Centers | $17.69M+74.0% | $17.55M+55.3% | $7.07M+30.1% | $8.9M+107% | $10.17M+197% | |
| Total Assets by Business | ||||||
| ADMA Bio Manufacturing | $1.64B+43.6% | $1.54B+41.3% | $1.39B+32.6% | $1.25B+19.9% | $1.14B+10.4% | |
| Plasma Collection Centers | $109.94M-12.0% | $112.33M-14.4% | $114.31M-15.7% | $120.47M-12.7% | $124.92M-11.9% | |
| Selling And Marketing Expense by Business | ||||||
| ADMA Bio Manufacturing | $27.89M+28.2% | $26.74M+32.8% | $25.37M+30.5% | $23.12M+27.5% | $21.76M+19.3% | |
| Plasma Collection Centers | $0— | $0— | $0— | $0— | $0— | |
| Segment Expenditure Addition To Long Lived Assets by Business | ||||||
| ADMA Bio Manufacturing | $20.22M+110% | $22.4M+209% | $24.02M+315% | $10.43M+96.9% | $9.61M+98.9% | |
| Plasma Collection Centers | $556K+170% | $550K+172% | $424K+337% | $141K-48.2% | $206K-39.9% | |
| General And Administrative Expense by Business | ||||||
| Plasma Collection Centers | $0— | $0— | $0— | $0— | $0— | |
| Research And Development Expense by Business | ||||||
| ADMA Bio Manufacturing | $6.53M+198% | $4.76M+162% | $3.78M+68.0% | $2.66M0.0% | $2.19M-25.2% | |
| Plasma Collection Centers | $0— | $0— | $0— | $0— | $0— | |
| Revenue by Geography | ||||||
| Non Us | $3.1M-81.2% | $6.11M-62.6% | $7.18M-56.1% | $12.03M-13.8% | $16.49M+26.9% | |
| US | $506.76M+14.4% | $504.07M+22.9% | $481.38M+31.4% | $462.15M+46.1% | $442.89M+63.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ADMA Biologics break its business down?
- ADMA Biologics (ADMA) reports business acquisitions pro forma revenue by business across 2 parts — ADMA Bio Manufacturing and Plasma Collection Centers. Each is extracted from the segment footnotes and tracked over time.
- Where does ADMA Biologics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ADMA Biologics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.